TGI
TRV GP III Portfolio holdings
AUM
$6.14M
This Quarter Return
-16.1%
1 Year Return
+45.44%
3 Year Return
+169.05%
5 Year Return
+771.75%
10 Year Return
–
AUM
$368M
AUM Growth
+$368M
(+62%)
Cap. Flow
+$198M
Cap. Flow
% of AUM
53.79%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
5
New
1
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Revolution Medicines
RVMD
|
$198M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Revolution Medicines
RVMD
$7.1B
| $198M | 53.79% |
+9,024,031
| New | +$198M |
|
2
Fulcrum Therapeutics
FULC
$351M
| $71.2M | 19.37% |
5,962,202
| – | – |
|
3
Voyager Therapeutics
VYGR
$186M
| $58.5M | 15.91% |
6,391,176
| – | – |
|
|
NTGN
4
DELISTED
Neon Therapeutics, Inc. Common Stock
NTGN
| $25.7M | 7% |
9,741,636
| – | – |
|
|
JNCE
5
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $14.5M | 3.94% |
3,048,780
| – | – |
|